Whittier Trust CO Enzon Pharmaceuticals, Inc. Transaction History
Whittier Trust CO
- $7.37 Billion
- Q3 2024
About ENZON PHARMACEUTICALS, INC.
- Ticker ENZN
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 74,214,600
- Market Cap $12.6M
- Description
- Enzon Pharmaceuticals, Inc., together with its subsidiaries, engages in marketing drug products. The company's marketed drug product is PegIntron. It also has a marketing agreement relating to Vicineum drug. The company was founded in 1981 and is headquartered in Cranford, New Jersey.